Sana Biotechnology Highlights Hypoimmune Allogeneic CAR T Cell Programs and in vivo ...

Retrieved on: 2022-12-11 22:41:59

Tags for this article:

Click the tags to see associated articles and topics

Sana Biotechnology Highlights Hypoimmune Allogeneic CAR T Cell Programs and in vivo .... View article details on hiswai:

Excerpt

Sana Biotechnology, Inc. Transplanted hypoimmune (HIP)-modified allogeneic CD19-targeted CAR T cells control CD19+ tumor cells in fully ...

Article found on: www.yahoo.com